RVTY Revvity Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RVTY

Price (delayed)

$130.63

Market cap

$14.58B

P/E Ratio

62.5

Dividend/share

$0.28

EPS

$2.09

Enterprise value

$16.9B

?
Relative Growth: Rel. Growth: 22
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: 20
Relative Profitability: Rel. Profitability: 51

The PerkinElmer Life Sciences and Diagnostics company – which is to be renamed during the second quarter of 2023 – provides end-to-end solutions that help scientists, researchers and clinicians better ...

Highlights
The company's revenue rose by 4.1% YoY
The gross profit has grown by 2.3% YoY
The quick ratio has decreased by 45% YoY but it has increased by 9% QoQ
The stock's price to earnings (P/E) is 62% more than its 5-year quarterly average of 38.6 and 34% more than its last 4 quarters average of 46.5
Revvity's net income has decreased by 17% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.perkinelmer.com
Peers: QTRX PRPO MTD

Key stats

What are the main financial stats of RVTY

RVTY stock price

How has the Revvity stock price performed over time
Intraday
-0.24%
1 week
0.71%
1 month
13.37%
1 year
56.71%
YTD
35.02%
QTD
17.41%

Financial performance

How have Revvity's revenue and profit performed over time
Revenue
$2.91B
Gross profit
$1.6B
Operating income
$358.85M
Net income
$237.55M
Gross margin
55%
Net margin
8.2%
RVTY's net margin is down by 20% year-on-year
Revvity's net income has decreased by 17% YoY
The company's operating margin fell by 10% YoY
The company's operating income fell by 6% YoY

Price vs fundamentals

How does RVTY's price correlate with its fundamentals

Growth

What is Revvity's growth rate over time

Valuation

What is Revvity stock price valuation
RVTY P/E details
P/E
62.5
P/B
2.02
P/S
5.01
EV/EBIT
47.06
EV/EBITDA
21.91
EV/Sales
5.8
The stock's price to earnings (P/E) is 62% more than its 5-year quarterly average of 38.6 and 34% more than its last 4 quarters average of 46.5
The EPS has contracted by 11% YoY
The price to book (P/B) is 35% higher than the last 4 quarters average of 1.5
The equity is down by 4.3% year-on-year
The price to sales (P/S) is 32% higher than the last 4 quarters average of 3.8 and 4.4% higher than the 5-year quarterly average of 4.8
The company's revenue rose by 4.1% YoY

Efficiency

How efficient is Revvity business performance
The company's return on assets fell by 13% YoY
The ROS has contracted by 11% YoY
RVTY's return on equity is down by 11% year-on-year
RVTY's return on invested capital is up by 3.8% year-on-year and by 2.5% since the previous quarter

Dividends

What is RVTY's dividend history
Dividend details
DPS
$0.28
Dividend yield
0.21%
Payout ratio
13.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Revvity financials performed over time
The total assets is 150% greater than the total liabilities
The current ratio has contracted by 46% YoY but it has grown by 4.7% from the previous quarter
The quick ratio has decreased by 45% YoY but it has increased by 9% QoQ
RVTY's debt is 54% smaller than its equity
The equity is down by 4.3% year-on-year
RVTY's debt to equity is up by 2.2% year-on-year but it is down by 2.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.